Berall v. Verathon Inc

CourtDistrict Court, W.D. Washington
DecidedNovember 4, 2022
Docket2:21-cv-00944
StatusUnknown

This text of Berall v. Verathon Inc (Berall v. Verathon Inc) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Berall v. Verathon Inc, (W.D. Wash. 2022).

Opinion

6 UNITED STATES DISTRICT COURT 7 WESTERN DISTRICT OF WASHINGTON 8 AT SEATTLE

9 JONATHAN BERALL, M.D., M.P.H., Case No. C21-944-RSM 10

11 Plaintiff, ORDER RE: CLAIMS CONSTRUCTION

12 v. 13 VERATHON INC., 14 Defendant. 15

16 I. INTRODUCTION 17 This matter comes before the Court on the parties’ briefs regarding Claim Construction. 18 Dkts. #369 and #370. Oral argument was held on May 6, 2022, pursuant to Markman v. 19 Westview Instruments, Inc., 52 F.3d 967 (Fed. Cir. 1995). Having reviewed all of the parties’ 20 briefing, and having considered the arguments and evidence presented in the Markman 21 22 Hearing, the Court makes the following rulings regarding the patent claim terms at issue. 23 II. BACKGROUND 24 Plaintiff Dr. Jonathan Berall alleges Defendant Verathon has infringed Patent No. 25 5,827,178 (“the Berall Patent”), titled “Laryngoscope for Use in Trachea Intubation.” 26 A laryngoscope is an essential tool used by physicians, emergency medical technicians, 27 28 and other medical practitioners to insert an endotracheal breathing tube (“ETT”) into a patient’s trachea, a procedure known as “intubation.” Dkt. #373-1 (“Ex. 1”), 1:22-26, Abstract, 1:5–10, 1 2 1:44–49. 3 The ETT provides life-saving oxygen to the non-breathing patient, like the majority of 4 those under general anesthesia, or critically ill or injured patients. Ex. 1, 1:66–2:6; Dkt. #373- 5 19 (“Ex. 7”) (U.S. Patent No. 5,263,472), 1:16–41. “Even in the best situations, intubation is 6 often difficult and can give rise to complications.” Dkt. #373-18 (“Ex. 6”) (U.S. Patent. No. 7 8 5,363,838 (“George ’838”)), 1:17–19; see also Ex. 1, 2:1–2. But intubation must often be 9 performed in awkward emergency sites, significantly increasing difficulty. Ex. 1, 2:2–4; Ex. 6, 10 1:26–28; Dkt. #373-2 (“Ex. 2”) at 34–35. It is essential to intubate critically injured patients 11 rapidly, as even brief oxygen deprivation can result in death or severe brain damage. Ex. 1, 12 13 1:35–41, 2:4–6; Ex. 6, 1:28–33; Ex. 7, 1:37–41. In the typical intubation procedure, the 14 Professional Intubator first grasps the handle of the laryngoscope in his or her nondominant 15 hand. Ex. 1, 1:44–53, 2:41–44, Figs. 1–2. A laryngoscope has a structure called a “blade” that 16 extends laterally from the handle. Ex. 1, 2:36–46, 5:5–21, 5:57–62. The end of the blade 17 nearest (most proximal to) the handle is the “proximal end,” and the end that is furthest (most 18 19 distant from) the handle is the “distal end.” Ex. 1, 5:13–21 & Figs. 2–4 (items 24–25). The 20 blade is inserted into the patient’s mouth to manipulate the tongue and other anatomical 21 structures, exposing the trachea. Ex. 1, 5:5–13, 5:15–18. While the Intubator holds the 22 laryngoscope (and thus the oral structures) steady using the non-dominant hand, in the 23 dominant hand he or she operates an intubating instrument (such as a stylet rod) to which the 24 25 ETT is attached, and guides the ETT behind the base of the tongue and into the trachea. Id., 26 1:44–49. 27 28 Traditional laryngoscopes had no camera—instead they required the Intubator to use the 1 2 laryngoscope to manipulate the oral structures to view the patient’s trachea directly by eye, an 3 approach now referred to as “direct laryngoscopy.” See Ex. 6, 5:25–46 (describing use of a 4 “standard laryngoscope”), Fig. 3 (parts 31, 33); Dkt. #373-20 (“Ex. 8”), 1:19–25; Dkt. #373-21 5 (“Ex. 9”) at 1–2. A major challenge in direct intubation was that a direct line of sight into the 6 patient’s airway may be blocked, such that the Intubator cannot see the trachea and would have 7 8 no choice but to attempt a “blind intubation.” Ex. 1, 2:6–20, 2:30–35. For example, the tongue 9 of a patient often slips over the blade, obstructing the physician’s direct view of the tracheal 10 opening, and vomiting, blood, abscesses, cancers, congenital abnormalities, and spasms can 11 also obstruct the view. Ex. 1, 2:6–29; Ex. 6, 1:19–26. Blind intubation is extremely 12 13 challenging and frequently unsuccessful. Ex. 1, 2:30–35; Ex. 6, 1:24–33. 14 Dr. Jonathan Berall, an emergency medicine physician, filed the application for the ’178 15 Patent on January 2, 1997. This patent is for a laryngoscope that addresses many of the above 16 problems by mounting a camera to the laryngoscope in a certain inventive way. See Ex. 1. 17 Medical scopes “used in association with screens, video systems, tapes and discs” were well 18 19 known prior to the ’178 patent. Id. at 3:11-13. For example, the ’178 patent describes earlier 20 “[s]copes used for arthroscopy with screens set on a monitor off to one side of an operating 21 room table.” Id. In these systems “[t]he screen, and with it the monitoring images is removed 22 from the direction of the operation.” Id. at 3:16-18. As a result, use of such devices “is not an 23 optimal answer for emergency intubation” because “the Professional Intubator has to turn his or 24 25 her head and body off to the side to . . . look at the screen.” Id. at 3:18-21, 3:32-35. The Berall 26 Patent includes diagrams showing the display screen mounted on the handle of the 27 28 laryngoscope; this is the subject of at least some of the claims in the patent. The ’178 Patent 1 2 issued on October 27, 1998. 3 On July 30, 2010, after years of attempting to license the patent to various laryngoscope 4 manufacturers practicing his invention, Dr. Berall filed the present action. Dkt. #1. This case 5 was stayed almost nine years pending ex parte re-examinations filed by Verathon and former 6 defendant Hoya, all of which were ultimately merged by the US PTO. See Dkt. #124. On 7 8 January 4, 2019, the Patent Office confirmed the validity of the ’178 Patent, concluding the 9 prior art did not render the claimed inventions obvious. See Ex Parte Berall, 2019 WL 140713 10 (P.T.A.B. Jan. 4, 2019); Dkt. #124. 11 This case was transferred in from the Southern District of New York on July 15, 2021. 12 13 See Docket. 14 Defendant Verathon is alleged to have infringed the Berall Patent, but further details 15 about the company are irrelevant for this Order. 16 The parties have deferred a discussion of indefiniteness of claim terms to the summary 17 judgment phase. Dkt. #367 at 2–3. 18 19 The parties submitted a Joint Claim Construction and Prehearing Statement that 20 identified certain claim terms in dispute. Dkt. #367. The parties agree that “said power supply 21 means” in claim 4 should be construed as “the power supply means of claim 3.” The parties 22 agree that the term “laryngoscope” in the preambles of claims 1 and 15 is limiting. The parties 23 also submitted an 87-page chart containing their proposed constructions of and supporting 24 25 evidence for the following terms: 26 Term Dr. Berall’s Construction Verathon’s Construction 27 “display means [for Not means plus function, no Means-plus-function. displaying the visual construction needed. If Function: “displaying the 28 field at a preselected construction is necessary: visual field at a preselected location / for the “display.” In the alternative, if location; displaying the field 1 Professional Intubator means-plus-function, of view.” Structure: “screen 2 to see the field of corresponding structure is mountable to the view]” “portable lightweight screen laryngoscope.” In the 3 operatively connected to said alternative, if determined not camera.” to be means-plus-function, 4 “display means” should be 5 construed as “screen mountable to the 6 laryngoscope.” “at a preselected No construction needed. At a consistent location 7 location” close to the intubator’s direct 8 line of sight to the patient’s throat; not to the side. 9 “camera means [for Not means-plus-function, no Means plus function. 10 observing a visual construction necessary.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Abbott Laboratories v. Sandoz, Inc.
566 F.3d 1282 (Federal Circuit, 2009)
Felix v. American Honda Motor Co., Inc.
562 F.3d 1167 (Federal Circuit, 2009)
TriMed, Inc. v. Stryker Corp.
514 F.3d 1256 (Federal Circuit, 2008)
Research Plastics, Inc. v. Federal Packaging Corp.
421 F.3d 1290 (Federal Circuit, 2005)
Rhodia Chimie & Rhodia, Inc. v. PPG Industries Inc.
402 F.3d 1371 (Federal Circuit, 2005)
Envirco Corporation v. Clestra Cleanroom, Inc.
209 F.3d 1360 (Federal Circuit, 2000)
United States v. Brennan
468 F. Supp. 2d 400 (E.D. New York, 2007)
Ali Hamza Ahmad al Bahlul v. United States
792 F.3d 1 (D.C. Circuit, 2015)
Richard Williamson v. Citrix Online, LLC
792 F.3d 1339 (Federal Circuit, 2015)
Teva Pharm. United States, Inc. v. Sandoz, Inc.
135 S. Ct. 831 (Supreme Court, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Berall v. Verathon Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/berall-v-verathon-inc-wawd-2022.